Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Cassinelli

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Tumori|April 23, 2016
The roots of modern oncology: from discovery of new antitumor anthracyclines to their clinical useGiuseppe Cassinelli
International Journal of Cardiology|June 7, 2016
Old and new applications of non-anticoagulant heparinGiuseppe Cassinelli, Annamaria Naggi
Molecules (Basel, Switzerland)|February 1, 2018
Looking Forward to the Future of Heparin: New Sources, Developments and ApplicationsGiangiacomo Torri, Giuseppe Cassinelli
Molecules (Basel, Switzerland)|February 1, 2018
Remembering Professor Benito Casu (1927-2016)Giangiacomo Torri, Giuseppe Cassinelli
Advances in Experimental Medicine and Biology|April 11, 2020
Non-Anticoagulant Heparins as Heparanase InhibitorsGiuseppe Cassinelli, Giangiacomo Torri, Annamaria Naggi
Analytical and Bioanalytical Chemistry|November 21, 2013
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragmentsAnna Alekseeva, Benito Casu, Giuseppe Cassinelli, et al.
The Journal of Biological Chemistry|January 14, 2005
Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splittingAnnamaria Naggi, Benito Casu, Marta Perez, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 30, 2015
Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparinsAnnamaria Naggi, Cristina Gardini, Giacomo Pedrinola, et al.
Journal of Medicinal Chemistry|February 6, 2004
Undersulfated and glycol-split heparins endowed with antiangiogenic activityBenito Casu, Marco Guerrini, Sara Guglieri, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Tumori|April 23, 2016
The roots of modern oncology: from discovery of new antitumor anthracyclines to their clinical useGiuseppe Cassinelli
International Journal of Cardiology|June 7, 2016
Old and new applications of non-anticoagulant heparinGiuseppe Cassinelli, Annamaria Naggi
Molecules (Basel, Switzerland)|February 1, 2018
Looking Forward to the Future of Heparin: New Sources, Developments and ApplicationsGiangiacomo Torri, Giuseppe Cassinelli
Molecules (Basel, Switzerland)|February 1, 2018
Remembering Professor Benito Casu (1927-2016)Giangiacomo Torri, Giuseppe Cassinelli
Advances in Experimental Medicine and Biology|April 11, 2020
Non-Anticoagulant Heparins as Heparanase InhibitorsGiuseppe Cassinelli, Giangiacomo Torri, Annamaria Naggi
Analytical and Bioanalytical Chemistry|November 21, 2013
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragmentsAnna Alekseeva, Benito Casu, Giuseppe Cassinelli, et al.
The Journal of Biological Chemistry|January 14, 2005
Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splittingAnnamaria Naggi, Benito Casu, Marta Perez, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 30, 2015
Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparinsAnnamaria Naggi, Cristina Gardini, Giacomo Pedrinola, et al.
Journal of Medicinal Chemistry|February 6, 2004
Undersulfated and glycol-split heparins endowed with antiangiogenic activityBenito Casu, Marco Guerrini, Sara Guglieri, et al.
Pageof 1